Skocz do pozycji: 1.

Tytuł:

Primary extraskeletal intradural Ewing sarcoma with acute hemorrhage: a case report and review of the literature.

Autorzy:

Salama H; Medical Research Club, Faculty of Medicine, Al-Quds University, Jerusalem, Palestine.
Abu-Hilal LH; Medical Research Club, Faculty of Medicine, Al-Quds University, Jerusalem, Palestine. lila_.
Idkedek M; Medical Research Club, Faculty of Medicine, Al-Quds University, Jerusalem, Palestine.
Kharousha A; Department of Neurosurgery, Al-Istishari Arab Hospital, Ramallah, West Bank, Palestine.
Abulihya M; Department of Pathology, Al-Istishari Arab Hospital, Ramallah, West Bank, Palestine.
Nimer H; Department of Neurosurgery, Al-Istishari Arab Hospital, Ramallah, West Bank, Palestine.

Pokaż więcej

Źródło:

Journal of medical case reports [J Med Case Rep] 2024 Mar 09; Vol. 18 (1), pp. 144. Date of Electronic Publication: 2024 Mar 09.

Typ publikacji:

Systematic Review; Case Reports; Journal Article

MeSH Terms:

Sarcoma, Ewing*/complications
Sarcoma, Ewing*/diagnostic imaging
Sarcoma, Ewing*/therapy
Spinal Cord Neoplasms*/diagnosis
Spinal Cord Neoplasms*/diagnostic imaging
Spinal Neoplasms*
Humans ; Male ; Middle Aged ; Prognosis

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 2.

Tytuł:

Incidence of skeletal-related events in patients with Ewing sarcoma: An observational retrospective study in Japan.

Autorzy:

Aiba H; Department of Medical Oncology, National Cancer Center Hospital, National Cancer Center Hospital, Tokyo, Japan.; Department of Orthopaedic Surgery, Nagoya City University, Nagoya, Japan.
Kojima Y; Department of Medical Oncology, National Cancer Center Hospital, National Cancer Center Hospital, Tokyo, Japan.
Shimoi T; Department of Medical Oncology, National Cancer Center Hospital, National Cancer Center Hospital, Tokyo, Japan.
Sudo K; Department of Medical Oncology, National Cancer Center Hospital, National Cancer Center Hospital, Tokyo, Japan.
Yazaki S; Department of Medical Oncology, National Cancer Center Hospital, National Cancer Center Hospital, Tokyo, Japan.
Imai T; Department of Medical Oncology, National Cancer Center Hospital, National Cancer Center Hospital, Tokyo, Japan.
Yoshida A; Department of Diagnostic Pathology, National Cancer Center Hospital, National Cancer Center Hospital, Tokyo, Japan.
Iwata S; Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, National Cancer Center Hospital, Tokyo, Japan.
Kobayashi E; Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, National Cancer Center Hospital, Tokyo, Japan.
Kawai A; Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, National Cancer Center Hospital, Tokyo, Japan.
Arakawa A; Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan.
Ogawa C; Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan.
Kimura H; Department of Orthopaedic Surgery, Nagoya City University, Nagoya, Japan.
Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, National Cancer Center Hospital, Tokyo, Japan.

Pokaż więcej

Źródło:

Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5), pp. e7060.

Typ publikacji:

Observational Study; Journal Article

MeSH Terms:

Sarcoma, Ewing*/epidemiology
Sarcoma, Ewing*/therapy
Hypercalcemia*
Spinal Cord Compression*/epidemiology
Spinal Cord Compression*/etiology
Neoplasms, Second Primary*
Humans ; Young Adult ; Adult ; Retrospective Studies ; Japan/epidemiology ; Incidence

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 3.

Tytuł:

Adamantinoma-Like Ewing Sarcoma Mimicking Merkel Cell Carcinoma in the Parotid Gland: A Diagnostic Pitfall.

Autorzy:

Saikia K; Department of Pathology and Laboratory Medicine, Henry Ford Health, Detroit, MI, USA.
Alruwaii FI; Department of Pathology and Laboratory Medicine, Henry Ford Health, Detroit, MI, USA.
Wu V; Department of Otolaryngology, Henry Ford Health, Detroit, MI, USA.
Keller C; Department of Pathology and Laboratory Medicine, Henry Ford Health, Detroit, MI, USA.
Chitale D; Department of Pathology and Laboratory Medicine, Henry Ford Health, Detroit, MI, USA.
Al-Obaidy KI; Department of Pathology and Laboratory Medicine, Henry Ford Health, Detroit, MI, USA.

Pokaż więcej

Źródło:

International journal of surgical pathology [Int J Surg Pathol] 2024 Feb; Vol. 32 (1), pp. 115-118. Date of Electronic Publication: 2023 May 02.

Typ publikacji:

Case Reports; Journal Article

MeSH Terms:

Sarcoma, Ewing*/diagnosis
Sarcoma, Ewing*/genetics
Sarcoma, Ewing*/pathology
Adamantinoma*/diagnosis
Adamantinoma*/genetics
Adamantinoma*/surgery
Carcinoma, Merkel Cell*/pathology
Skin Neoplasms*/pathology
Female ; Humans ; Adult ; Parotid Gland/pathology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 4.

Tytuł:

Prognostic value of PRR11 and immune cell infiltration in Ewing sarcoma.

Autorzy:

Wen J; Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.; Department of Orthopedics, JXHC Key Laboratory of Digital Orthopedics, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.
Wan L; Department of Child Healthcare, Hunan Provincial Maternal and Child Health Hospital, Changsha, Hunan, China.
Dong X; Department of Orthopedics, JXHC Key Laboratory of Digital Orthopedics, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.

Pokaż więcej

Źródło:

PloS one [PLoS One] 2024 Mar 01; Vol. 19 (3), pp. e0299720. Date of Electronic Publication: 2024 Mar 01 (Print Publication: 2024).

Typ publikacji:

Journal Article

MeSH Terms:

Sarcoma*
Sarcoma, Ewing*/genetics
Adolescent ; Child ; Humans ; Algorithms ; Calibration ; Prognosis

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 5.

Tytuł:

A 13-Year-Old Boy with Chest Wall Actinomycosis Mimicking Ewing Sarcoma on Imaging.

Autorzy:

AlMuammar SA; Department of Family Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

Pokaż więcej

Źródło:

The American journal of case reports [Am J Case Rep] 2023 Nov 03; Vol. 24, pp. e941498. Date of Electronic Publication: 2023 Nov 03.

Typ publikacji:

Case Reports; Journal Article

MeSH Terms:

Sarcoma, Ewing*/diagnostic imaging
Sarcoma, Ewing*/complications
Thoracic Wall*/diagnostic imaging
Actinomycosis*/diagnostic imaging
Actinomycosis*/drug therapy
Male ; Humans ; Adolescent ; Actinomyces ; Amoxicillin

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 6.

Tytuł:

CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles.

Autorzy:

De Feo A; Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Manfredi M; Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.
Mancarella C; Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Maqueda JJ; Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
De Giorgis V; Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.
Pignochino Y; Department of Clinical and Biological Sciences, University of Turin, 10043 Turin, Italy.; Sarcoma Unit, Candiolo Cancer Institute, FPO-IRCCS, 10060 Turin, Italy.
Sciandra M; Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Cristalli C; Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Donadelli M; Department of Neurosciences, Biomedicine and Movement Sciences, Section of Biochemistry, University of Verona, 37134 Verona, Italy.
Scotlandi K; Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2024 Jan 27; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 27.

Typ publikacji:

Journal Article

MeSH Terms:

12E7 Antigen*/metabolism
Bone Neoplasms*/metabolism
Extracellular Vesicles*/metabolism
Sarcoma, Ewing*/pathology
Child ; Humans ; Cell Line, Tumor ; Cell Movement/genetics ; Gene Expression Regulation, Neoplastic ; Oncogene Proteins, Fusion/genetics ; Proteomics

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 7.

Tytuł:

IL-1 Family Members in Bone Sarcomas.

Autorzy:

Landuzzi L; Experimental Oncology Laboratory, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Ruzzi F; Laboratory of Immunology and Biology of Metastasis, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, Italy.
Pellegrini E; Experimental Oncology Laboratory, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Lollini PL; Laboratory of Immunology and Biology of Metastasis, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, Italy.
Scotlandi K; Experimental Oncology Laboratory, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Manara MC; Experimental Oncology Laboratory, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Pokaż więcej

Źródło:

Cells [Cells] 2024 Jan 25; Vol. 13 (3). Date of Electronic Publication: 2024 Jan 25.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Sarcoma, Ewing*/pathology
Osteosarcoma*
Bone Neoplasms*/pathology
Humans ; Family ; Interleukin-1 ; Tumor Microenvironment

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 8.

Tytuł:

Report and literature review of four cases of EWSR1::NFATC2 round cell sarcoma.

Autorzy:

Liu L; Department of Pathology, Peking University People's Hospital, Beijing, People's Republic of China.
Li L; Department of Pathology, Beijing Jishuitan Hospital, The Fourth Medical College of Peking University, Beijing, People's Republic of China.
Ding Y; Department of Pathology, Beijing Jishuitan Hospital, The Fourth Medical College of Peking University, Beijing, People's Republic of China.
Kong F; Department of Pathology, Peking University People's Hospital, Beijing, People's Republic of China.
Mo W; Department of Pathology, Affiliated Hospital of Guilin Medical University, Guilin, People's Republic of China.
Ye H; Department of Histopathology, Royal National Orthopaedic Hospital NHS Trust, Brockley Hill, Stanmore, Middlesex, HA7 4LP, UK. .
Shen D; Department of Pathology, Peking University People's Hospital, Beijing, People's Republic of China. .

Pokaż więcej

Źródło:

Diagnostic pathology [Diagn Pathol] 2024 Jan 22; Vol. 19 (1), pp. 19. Date of Electronic Publication: 2024 Jan 22.

Typ publikacji:

Review; Journal Article

MeSH Terms:

Neuroectodermal Tumors, Primitive, Peripheral*
Sarcoma*
Sarcoma, Ewing*
Soft Tissue Neoplasms*
Oncogene Proteins, Fusion*
Adolescent ; Adult ; Female ; Humans ; Male ; Young Adult ; Exons ; In Situ Hybridization, Fluorescence ; NFATC Transcription Factors/genetics ; Retrospective Studies ; RNA-Binding Protein EWS/genetics

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 9.

Tytuł:

The expression changes of PD-L1 and immune response mediators are related to the severity of primary bone tumors.

Autorzy:

Eghtedari AR; Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, P.O. Box: 1449614535, Tehran, Iran.
Vaezi MA; Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, P.O. Box: 1449614535, Tehran, Iran.
Safari E; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Salimi V; Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Safizadeh B; Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, P.O. Box: 1449614535, Tehran, Iran.
Babaheidarian P; Department of Pathology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Abiri A; Department of Obstetrics and Gynecology, Tehran University of Medical Sciences, Tehran, Iran.
Mahdinia E; Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, P.O. Box: 1449614535, Tehran, Iran.
Alireza Mirzaei; Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran.
Mokhles P; School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Tavakoli-Yaraki M; Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, P.O. Box: 1449614535, Tehran, Iran. .

Pokaż więcej

Źródło:

Scientific reports [Sci Rep] 2023 Nov 22; Vol. 13 (1), pp. 20474. Date of Electronic Publication: 2023 Nov 22.

Typ publikacji:

Journal Article

MeSH Terms:

Bone Neoplasms*/metabolism
Osteosarcoma*/pathology
Sarcoma, Ewing*/pathology
Humans ; B7-H1 Antigen/metabolism ; CD8-Positive T-Lymphocytes/metabolism ; Immunity ; Immunologic Factors/metabolism ; Transforming Growth Factor beta/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 10.

Tytuł:

A Rare Case of Primary Intracranial Ewing's Sarcoma.

Autorzy:

Ghosh A; Department of Radiation Oncology, National Cancer Institute, All India Institute of Medical Sciences, New Delhi, India.
Bharat RP; Department of Radiation Oncology, National Cancer Institute, All India Institute of Medical Sciences, New Delhi, India.
Das S; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
Kumar A; Department of Medical Oncology, National Cancer Institute, All India Institute of Medical Sciences, New Delhi, India.
Sharma MC; Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
Gupta D; Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India.
Mallick S; Department of Radiation Oncology, National Cancer Institute, All India Institute of Medical Sciences, New Delhi, India.

Pokaż więcej

Źródło:

Neurology India [Neurol India] 2023 Nov-Dec; Vol. 71 (6), pp. 1268-1269.

Typ publikacji:

Case Reports; Letter

MeSH Terms:

Sarcoma, Ewing*/diagnostic imaging
Humans ; Biomarkers, Tumor

Raport

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 11.

Tytuł:

EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma.

Autorzy:

Yasir M; Department of Pharmacology, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.
Park J; Department of Pharmacology, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.
Chun W; Department of Pharmacology, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 Oct 14; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 14.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Bone Neoplasms*/therapy
Bone Neoplasms*/drug therapy
Sarcoma, Ewing*/therapy
Sarcoma, Ewing*/drug therapy
Adolescent ; Adult ; Humans ; Cell Line, Tumor ; Epigenesis, Genetic ; Gene Expression Regulation, Neoplastic ; Oncogene Proteins, Fusion/genetics ; Oncogene Proteins, Fusion/metabolism ; Proteins/metabolism ; Proto-Oncogene Protein c-fli-1/genetics ; Proto-Oncogene Protein c-fli-1/metabolism ; RNA-Binding Protein EWS/genetics ; RNA-Binding Protein EWS/metabolism ; Tumor Microenvironment

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 12.

Tytuł:

CRISPR-Cas9 knockout screening identifies KIAA1429 as an essential gene in Ewing sarcoma.

Autorzy:

Tan K; Department of General Surgery, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Lu W; Shanghai Key Laboratory of Reproductive Medicine, Department of Histoembryology, Genetics and Developmental Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chen F; Department of General Surgery, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shi H; Department of General Surgery, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ma Y; Department of General Surgery, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chen Z; Department of General Surgery, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wu W; Department of General Surgery, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Lv Z; Department of General Surgery, Shanghai Children's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .
Mo J; Shanghai Key Laboratory of Reproductive Medicine, Department of Histoembryology, Genetics and Developmental Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .

Pokaż więcej

Źródło:

Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Sep 28; Vol. 42 (1), pp. 250. Date of Electronic Publication: 2023 Sep 28.

Typ publikacji:

Journal Article

MeSH Terms:

Sarcoma, Ewing*/genetics
Sarcoma, Ewing*/pathology
Animals ; Humans ; Child ; Genes, Essential ; CRISPR-Cas Systems ; Cell Line, Tumor ; Disease Models, Animal ; Cell Proliferation

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 13.

Tytuł:

Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study.

Autorzy:

Peretz Soroka H; Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
Vora T; Division of Hematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Noujaim J; Division of Medical Oncology, Hôpital Maisonneuve Rosemont, University of Montreal, Montreal, Quebec, Canada.
Marcoux N; Division of Hematology-Oncology, Centre Hospitalier Universitaire de Québec, Quebec, Canada.
Cohen-Gogo S; Division of Hematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Alcindor T; Division of Medical Oncology, McGill University Health Centre, Montreal, Quebec, Canada.
Holloway C; Division of Radiation Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada.
Rodrigues C; Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
Karachiwala H; Division of Medical Oncology, Cross Cancer Institute, Alberta Health Services, Edmonton, Alberta, Canada.
Alvi S; Division of Pediatric Hematology/Oncology, Jim Pattison Children's Hospital Saskatoon, Saskatoon, Saskatchewan, Canada.
Lee U; Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada.
Cheng S; Division of Pediatric Hematology/Oncology/BMT, B.C. Children's Hospital, BC Cancer, Vancouver, British Columbia, Canada.
Banerji S; Department of Pediatric Hematology-Oncology, CancerCare Manitoba Research Institute, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Oberoi S; Department of Pediatric Hematology-Oncology, CancerCare Manitoba Research Institute, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Feng X; Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada.
Smrke A; Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada.
Simmons C; Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada.
Razak AA; Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.; Division of Medical Oncology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
Gupta AA; Division of Medical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.; Division of Hematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Pokaż więcej

Źródło:

Cancer medicine [Cancer Med] 2023 Sep; Vol. 12 (18), pp. 18872-18881. Date of Electronic Publication: 2023 Sep 19.

Typ publikacji:

Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Bone Neoplasms*/drug therapy
Bone Neoplasms*/pathology
Sarcoma*/drug therapy
Sarcoma, Ewing*/drug therapy
Sarcoma, Ewing*/pathology
Osteosarcoma*/pathology
Chondrosarcoma*
Soft Tissue Neoplasms*
Humans ; Adult ; Child ; Adolescent ; Young Adult ; Middle Aged ; Aged ; Tyrosine Kinase Inhibitors ; Neoplasm Recurrence, Local/drug therapy ; Canada ; Retrospective Studies

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 14.

Tytuł:

Clinical features and outcomes of infantile soft-tissue sarcoma: A multicenter retrospective study in Beijing.

Autorzy:

Zhu S; Department of Medical Oncology, Pediatric Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China.
Xu N; Department of Medical Oncology, Pediatric Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China.
Zhi T; Department of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Gao Y; Department of Pediatrics, Peking University First Hospital, Beijing, China.
Zhong D; Department of Hematology, Capital Institute of Pediatrics, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Zhang W; Department of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Jin M; Department of Medical Oncology, Pediatric Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China.
Sun Q; Department of Pediatrics, Peking University First Hospital, Beijing, China.
Xie Y; Department of Pediatrics, Peking University First Hospital, Beijing, China.
Zhang X; Department of Hematology, Capital Institute of Pediatrics, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Li L; Department of Hematology, Capital Institute of Pediatrics, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Wang S; Department of Otorhinolaryngology Head and Neck Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Wang H; Department of Surgical Oncology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Liu R; Department of Hematology, Capital Institute of Pediatrics, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Zhao W; Department of Pediatrics, Peking University First Hospital, Beijing, China.
Huang D; Department of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Ni X; Department of Otorhinolaryngology Head and Neck Surgery, Capital Medical University, National Center for Children's Health, Beijing, China.
Ma X; Department of Medical Oncology, Pediatric Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Hematology Oncology, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing, China.

Pokaż więcej

Źródło:

Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Aug; Vol. 19 (4), pp. 876-880.

Typ publikacji:

Journal Article; Multicenter Study

MeSH Terms:

Rhabdomyosarcoma*
Sarcoma*/diagnosis
Sarcoma*/epidemiology
Sarcoma*/therapy
Sarcoma, Ewing*/diagnosis
Sarcoma, Ewing*/epidemiology
Sarcoma, Ewing*/therapy
Soft Tissue Neoplasms*/diagnosis
Soft Tissue Neoplasms*/epidemiology
Soft Tissue Neoplasms*/therapy
Child ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; China/epidemiology ; Multicenter Studies as Topic ; Retrospective Studies ; Child, Preschool

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 15.

Tytuł:

Tumor-suppressive microRNA-152 inhibits the proliferation of Ewing's sarcoma cells by targeting CDK5R1.

Autorzy:

Kawano M; Department of Orthopaedic Surgery, Faculty of Medicine, Oita University, Oita, 879-5593, Japan.
Tanaka K; Department of Orthopaedic Surgery, Faculty of Medicine, Oita University, Oita, 879-5593, Japan. .
Itonaga I; Department of Orthopaedic Surgery, Faculty of Medicine, Oita University, Oita, 879-5593, Japan.
Iwasaki T; Department of Orthopaedic Surgery, Faculty of Medicine, Oita University, Oita, 879-5593, Japan.
Kubota Y; Department of Orthopaedic Surgery, Faculty of Medicine, Oita University, Oita, 879-5593, Japan.
Tsumura H; Department of Orthopaedic Surgery, Faculty of Medicine, Oita University, Oita, 879-5593, Japan.

Pokaż więcej

Źródło:

Scientific reports [Sci Rep] 2023 Oct 29; Vol. 13 (1), pp. 18546. Date of Electronic Publication: 2023 Oct 29.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Sarcoma, Ewing*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
Neuroectodermal Tumors, Primitive, Peripheral*
Bone Neoplasms*/pathology
Humans ; Cell Proliferation/genetics ; Transcription Factors ; Cyclin-Dependent Kinases ; Cell Line, Tumor

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 16.

Tytuł:

Histone Methyltransferases G9a/ Ehmt2 and GLP/ Ehmt1 Are Associated with Cell Viability and Poorer Prognosis in Neuroblastoma and Ewing Sarcoma.

Autorzy:

Souza BK; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre 90035-003, Brazil.; National Science and Technology Institute for Children's Cancer Biology and Pediatric Oncology-INCT BioOncoPed, Porto Alegre 90035-003, Brazil.; Epigenica Biosciences, Canoas 92035-000, Brazil.
Freire NH; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre 90035-003, Brazil.; National Science and Technology Institute for Children's Cancer Biology and Pediatric Oncology-INCT BioOncoPed, Porto Alegre 90035-003, Brazil.; Children's Cancer Institute, Porto Alegre 90620-110, Brazil.
Monteiro TS; Epigenica Biosciences, Canoas 92035-000, Brazil.
Herlinger AL; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre 90035-003, Brazil.; National Science and Technology Institute for Children's Cancer Biology and Pediatric Oncology-INCT BioOncoPed, Porto Alegre 90035-003, Brazil.
Jaeger M; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre 90035-003, Brazil.; National Science and Technology Institute for Children's Cancer Biology and Pediatric Oncology-INCT BioOncoPed, Porto Alegre 90035-003, Brazil.; Children's Cancer Institute, Porto Alegre 90620-110, Brazil.
Dalmolin MGS; National Science and Technology Institute for Children's Cancer Biology and Pediatric Oncology-INCT BioOncoPed, Porto Alegre 90035-003, Brazil.; Children's Cancer Institute, Porto Alegre 90620-110, Brazil.
de Farias CB; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre 90035-003, Brazil.; National Science and Technology Institute for Children's Cancer Biology and Pediatric Oncology-INCT BioOncoPed, Porto Alegre 90035-003, Brazil.; Children's Cancer Institute, Porto Alegre 90620-110, Brazil.
Gregianin L; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre 90035-003, Brazil.; National Science and Technology Institute for Children's Cancer Biology and Pediatric Oncology-INCT BioOncoPed, Porto Alegre 90035-003, Brazil.; Children's Cancer Institute, Porto Alegre 90620-110, Brazil.; Department of Pediatrics, School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre 90035-003, Brazil.; Pediatric Oncology Service, Clinical Hospital, Federal University of Rio Grande do Sul, Porto Alegre 90035-003, Brazil.
Brunetto AT; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre 90035-003, Brazil.; National Science and Technology Institute for Children's Cancer Biology and Pediatric Oncology-INCT BioOncoPed, Porto Alegre 90035-003, Brazil.; Children's Cancer Institute, Porto Alegre 90620-110, Brazil.
Brunetto AL; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre 90035-003, Brazil.; National Science and Technology Institute for Children's Cancer Biology and Pediatric Oncology-INCT BioOncoPed, Porto Alegre 90035-003, Brazil.; Children's Cancer Institute, Porto Alegre 90620-110, Brazil.
Thiele CJ; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Roesler R; Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre 90035-003, Brazil.; National Science and Technology Institute for Children's Cancer Biology and Pediatric Oncology-INCT BioOncoPed, Porto Alegre 90035-003, Brazil.; Department of Pharmacology, Institute for Basic Health Sciences, Federal University of Rio Grande do Sul, Porto Alegre 90035-003, Brazil.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 Oct 17; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 17.

Typ publikacji:

Journal Article

MeSH Terms:

Neuroblastoma*/genetics
Sarcoma, Ewing*/genetics
Child ; Humans ; Cell Survival/genetics ; Epigenesis, Genetic ; Histocompatibility Antigens/genetics ; Histocompatibility Antigens/metabolism ; Histone Methyltransferases/metabolism ; Histone-Lysine N-Methyltransferase/genetics ; Histone-Lysine N-Methyltransferase/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 17.

Tytuł:

An exploratory study of cell stiffness as a mechanical label-free biomarker across multiple musculoskeletal sarcoma cells.

Autorzy:

Daniel C; Laboratory of Cell Biology, Department of Orthopedic Surgery, University Hospital of Tübingen, 72076, Tübingen, Germany. .; Department of Orthopedic Surgery, University Hospital of Tübingen, 72076, Tübingen, Germany. .
Traub F; Department of Orthopedic Surgery, University Hospital of Tübingen, 72076, Tübingen, Germany.; Department of Orthopedics and Traumatology, University Medical Center Mainz, Johannes Gutenberg-University Mainz, 55122, Mainz, Germany.
Sachsenmaier S; Laboratory of Cell Biology, Department of Orthopedic Surgery, University Hospital of Tübingen, 72076, Tübingen, Germany.; Department of Orthopedic Surgery, University Hospital of Tübingen, 72076, Tübingen, Germany.
Riester R; Laboratory of Cell Biology, Department of Orthopedic Surgery, University Hospital of Tübingen, 72076, Tübingen, Germany.
Mederake M; Department of Trauma and Reconstructive Surgery, BG Clinic, University of Tübingen, 72076, Tübingen, Germany.
Konrads C; Department of Orthopedics and Traumatology, Hanseatic Hospital Stralsund, 18437, Stralsund, Germany.
Danalache M; Laboratory of Cell Biology, Department of Orthopedic Surgery, University Hospital of Tübingen, 72076, Tübingen, Germany.; Department of Orthopedic Surgery, University Hospital of Tübingen, 72076, Tübingen, Germany.

Pokaż więcej

Źródło:

BMC cancer [BMC Cancer] 2023 Sep 12; Vol. 23 (1), pp. 862. Date of Electronic Publication: 2023 Sep 12.

Typ publikacji:

Journal Article

MeSH Terms:

Sarcoma, Ewing*/genetics
Sarcoma*
Osteosarcoma*/genetics
Fibrosarcoma*
Rhabdomyosarcoma*/genetics
Chondrosarcoma*/genetics
Soft Tissue Neoplasms*
Bone Neoplasms*/genetics
Humans ; Tubulin ; Actins ; Biomarkers

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 18.

Tytuł:

Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma.

Autorzy:

Kim JA; Children's Cancer Therapy Development Institute, 9025 NE Von Neumann Drive Ste 110, Hillsboro, OR, 97006, USA. .
Crawford KA; Children's Cancer Therapy Development Institute, 9025 NE Von Neumann Drive Ste 110, Hillsboro, OR, 97006, USA.
Spada PA; Children's Cancer Therapy Development Institute, 9025 NE Von Neumann Drive Ste 110, Hillsboro, OR, 97006, USA.
Martin LR; Children's Cancer Therapy Development Institute, 9025 NE Von Neumann Drive Ste 110, Hillsboro, OR, 97006, USA.
Zhang J; Children's Cancer Therapy Development Institute, 9025 NE Von Neumann Drive Ste 110, Hillsboro, OR, 97006, USA.
Wong R; Children's Cancer Therapy Development Institute, 9025 NE Von Neumann Drive Ste 110, Hillsboro, OR, 97006, USA.
Reid JM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.
Stewart CF; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, 38105-2794, USA.
Frank TM; Children's Cancer Therapy Development Institute, 9025 NE Von Neumann Drive Ste 110, Hillsboro, OR, 97006, USA.
Liu Q; Department of Epidemiology and Biostatistics, University of Texas Health Science Center, San Antonio, TX, 78229, USA.
Michalek JE; Department of Epidemiology and Biostatistics, University of Texas Health Science Center, San Antonio, TX, 78229, USA.
Keller C; Children's Cancer Therapy Development Institute, 9025 NE Von Neumann Drive Ste 110, Hillsboro, OR, 97006, USA. .

Pokaż więcej

Źródło:

Scientific reports [Sci Rep] 2023 Sep 01; Vol. 13 (1), pp. 14360. Date of Electronic Publication: 2023 Sep 01.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Sarcoma, Ewing*/drug therapy
Neuroectodermal Tumors, Primitive, Peripheral*
Humans ; Animals ; Mice ; Enoxacin ; Benzamides ; Adjuvants, Immunologic ; Adjuvants, Pharmaceutic ; Disease Models, Animal ; Tumor Suppressor Protein p53

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 19.

Tytuł:

Poly(ADP-ribose) Polyremase-1 (PARP-1) Inhibition: A Promising Therapeutic Strategy for ETS-Expressing Tumours.

Autorzy:

Legrand AJ; CNRS, EMR9002 Integrative Structural Biology, F-59000 Lille, France.; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE-Risk Factors and Molecular Deter-minants of Aging-Related Diseases, F-59000 Lille, France.
Choul-Li S; Département de Biologie, Faculté des Sciences, Université Chouaib Doukkali, BP-20, El Jadida 24000, Morocco.
Villeret V; CNRS, EMR9002 Integrative Structural Biology, F-59000 Lille, France.; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE-Risk Factors and Molecular Deter-minants of Aging-Related Diseases, F-59000 Lille, France.
Aumercier M; CNRS, EMR9002 Integrative Structural Biology, F-59000 Lille, France.; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE-Risk Factors and Molecular Deter-minants of Aging-Related Diseases, F-59000 Lille, France.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 Aug 30; Vol. 24 (17). Date of Electronic Publication: 2023 Aug 30.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Leukemia*
Prostatic Neoplasms*
Sarcoma, Ewing*
Humans ; Poly Adenosine Diphosphate Ribose ; Poly(ADP-ribose) Polymerase Inhibitors/pharmacology ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 20.

Tytuł:

Radiotherapy in bone sarcoma: the quest for better treatment option.

Autorzy:

Locquet MA; Cell Death and Pediatric Cancer Team, Cancer Initiation and Tumor Cell Identity Department, INSERM1052, CNRS5286, Cancer Research Center of Lyon, F-69008, Lyon, France.
Brahmi M; Department of Medical Oncology, Centre Leon Berard, Unicancer Lyon, 69008, Lyon, France.
Blay JY; Cell Death and Pediatric Cancer Team, Cancer Initiation and Tumor Cell Identity Department, INSERM1052, CNRS5286, Cancer Research Center of Lyon, F-69008, Lyon, France.; Department of Medical Oncology, Centre Leon Berard, Unicancer Lyon, 69008, Lyon, France.; Université Claude Bernard Lyon I, Lyon, France.
Dutour A; Cell Death and Pediatric Cancer Team, Cancer Initiation and Tumor Cell Identity Department, INSERM1052, CNRS5286, Cancer Research Center of Lyon, F-69008, Lyon, France. .

Pokaż więcej

Źródło:

BMC cancer [BMC Cancer] 2023 Aug 11; Vol. 23 (1), pp. 742. Date of Electronic Publication: 2023 Aug 11.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Sarcoma*/radiotherapy
Sarcoma*/surgery
Osteosarcoma*/pathology
Bone Neoplasms*/radiotherapy
Bone Neoplasms*/pathology
Sarcoma, Ewing*/pathology
Chondrosarcoma*/radiotherapy
Chondrosarcoma*/surgery
Child ; Young Adult ; Humans

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 21.

Tytuł:

Adamantinoma-like ewing sarcoma arising in the pancreatic tail: a case report of a rare entity and review of the literature.

Autorzy:

Wang Z; Department of Pathology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, 518033, China.; Department of Pathology, Sun Yat-sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, China.
Wen X; Department of Pathology, Sun Yat-sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, China.
Zhang Y; Department of Pathology, Sun Yat-sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, China. .
Zhang X; Department of Pathology, Sun Yat-sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, China. .

Pokaż więcej

Źródło:

Diagnostic pathology [Diagn Pathol] 2023 Jul 31; Vol. 18 (1), pp. 86. Date of Electronic Publication: 2023 Jul 31.

Typ publikacji:

Review; Case Reports; Journal Article

MeSH Terms:

Sarcoma, Ewing*/diagnosis
Sarcoma, Ewing*/genetics
Sarcoma, Ewing*/chemistry
Adamantinoma*/chemistry
Adamantinoma*/pathology
Neuroectodermal Tumors, Primitive, Peripheral*/pathology
Skin Neoplasms*/pathology
Middle Aged ; Humans ; Cytodiagnosis

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 22.

Tytuł:

CD44 Modulates Cell Migration and Invasion in Ewing Sarcoma Cells.

Autorzy:

Fernández-Tabanera E; Unidad de Tumores Sólidos Infantiles, Instituto de Investigación de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III (U758, CB06/07/1009, CIBERER-ISCIII), 28029 Madrid, Spain.; Universidad Nacional de Educación a Distancia (UNED), 28015 Madrid, Spain.
García-García L; Unidad de Tumores Sólidos Infantiles, Instituto de Investigación de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain.
Rodríguez-Martín C; Unidad de Tumores Sólidos Infantiles, Instituto de Investigación de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III (U758, CB06/07/1009, CIBERER-ISCIII), 28029 Madrid, Spain.
Cervera ST; Unidad de Tumores Sólidos Infantiles, Instituto de Investigación de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III (U758, CB06/07/1009, CIBERER-ISCIII), 28029 Madrid, Spain.
González-González L; Unidad de Tumores Sólidos Infantiles, Instituto de Investigación de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain.
Robledo C; Unidad de Tumores Sólidos Infantiles, Instituto de Investigación de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain.
Josa S; Unidad de Tumores Sólidos Infantiles, Instituto de Investigación de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain.
Martínez S; Unidad de Tumores Sólidos Infantiles, Instituto de Investigación de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain.
Chapado L; Bioinformatics Unit, Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain.
Monzón S; Bioinformatics Unit, Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain.
Melero-Fernández de Mera RM; Unidad de Tumores Sólidos Infantiles, Instituto de Investigación de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III (U758, CB06/07/1009, CIBERER-ISCIII), 28029 Madrid, Spain.
Alonso J; Unidad de Tumores Sólidos Infantiles, Instituto de Investigación de Enfermedades Raras (IIER), Instituto de Salud Carlos III (ISCIII), 28220 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III (U758, CB06/07/1009, CIBERER-ISCIII), 28029 Madrid, Spain.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 Jul 21; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 21.

Typ publikacji:

Journal Article

MeSH Terms:

Sarcoma, Ewing*/genetics
Sarcoma, Ewing*/metabolism
Humans ; Hyaluronic Acid ; Cell Line, Tumor ; Oncogene Proteins, Fusion/genetics ; Oncogene Proteins, Fusion/metabolism ; Proto-Oncogene Protein c-fli-1/metabolism ; Cell Movement/genetics ; Gene Expression Regulation, Neoplastic ; Hyaluronan Receptors/genetics ; Hyaluronan Receptors/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 23.

Tytuł:

EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis.

Autorzy:

Chakraborty S; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, 68198, USA.; Department of Genetics, Cell Biology & Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Bhat AM; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, 68198, USA.; Department of Genetics, Cell Biology & Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Mushtaq I; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, 68198, USA.; Incyte Corporation, Wilmington, DE, USA.
Luan H; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Kalluchi A; Department of Genetics, Cell Biology & Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Mirza S; Department of Genetics, Cell Biology & Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, USA.; Department of Chemistry, College of Science, United Arab Emirates University, Al Ain, UAE.
Storck MD; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Chaturvedi N; Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Lopez-Guerrero JA; Laboratory of Molecular Biology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
Llombart-Bosch A; Department of Pathology, University of Valencia, Avd. Blasco Ibáñez 15, 46010, Valencia, Spain.
Machado I; Department of Pathology, University of Valencia, Avd. Blasco Ibáñez 15, 46010, Valencia, Spain.
Scotlandi K; Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Meza JL; Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, NE, 68198, USA.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Ghosal G; Department of Genetics, Cell Biology & Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, USA.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Coulter DW; Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE, 68198, USA.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Jordan Rowley M; Department of Genetics, Cell Biology & Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, USA.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Band V; Department of Genetics, Cell Biology & Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, USA.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
Mohapatra BC; Department of Genetics, Cell Biology & Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, USA. .; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198, USA. .
Band H; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, 68198, USA. .; Department of Genetics, Cell Biology & Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, USA. .; Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, NE, 68198, USA. .; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, 68198, USA. .

Pokaż więcej

Źródło:

Communications biology [Commun Biol] 2023 Jul 20; Vol. 6 (1), pp. 758. Date of Electronic Publication: 2023 Jul 20.

Typ publikacji:

Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't

MeSH Terms:

Sarcoma, Ewing*/genetics
Sarcoma, Ewing*/metabolism
Sarcoma, Ewing*/pathology
Mice ; Animals ; Receptor, IGF Type 1/genetics ; Receptor, IGF Type 1/metabolism ; Cell Membrane/metabolism ; Signal Transduction/physiology ; Carcinogenesis/genetics ; Carcinogenesis/metabolism ; Cell Transformation, Neoplastic/genetics ; Cell Transformation, Neoplastic/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 24.

Tytuł:

Simple and easily accessible prognostic markers in ewing sarcoma; neutrophil-lymphocyte ratio, neutrophil-platelet score and systemic-inflammation index.

Autorzy:

Bal O; Department of Medical Oncology, University of Health Science, Ankara City Hospital, Ankara, Turkey.
Acikgoz Y; Department of Medical Oncology, University of Health Science, Ankara City Hospital, Ankara, Turkey.
Yildiz B; Department of Medical Oncology, Gulhane Training and Research Hospital, Ankara, Turkey.
Kos FT; Department of Medical Oncology, University of Health Science, Ankara City Hospital, Ankara, Turkey.
Algin E; Department of Medical Oncology, University of Health Science, Ankara City Hospital, Ankara, Turkey.
Dogan M; Department of Medical Oncology, Dr. A.Y. Oncology Training and Research Hospital, Ankara, Turkey.

Pokaż więcej

Źródło:

Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Jul-Sep; Vol. 19 (5), pp. 1241-1247.

Typ publikacji:

Journal Article

MeSH Terms:

Sarcoma, Ewing*/diagnosis
Sarcoma, Ewing*/pathology
Humans ; Prognosis ; Neutrophils/pathology ; Retrospective Studies ; Lymphocytes/pathology ; Inflammation/pathology ; Tumor Microenvironment

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 25.

Tytuł:

Practical Management of Adult Ultra-Rare Primary Retroperitoneal Soft Tissue Sarcoma: A Focus on Perivascular Epithelioid Tumours and Extraosseous Ewing Sarcoma.

Autorzy:

Apte SS; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.; Division of General Surgery, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
Mor E; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
Mitchell C; Division of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.
Gyorki DE; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia.

Pokaż więcej

Źródło:

Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Jun 21; Vol. 30 (7), pp. 5953-5972. Date of Electronic Publication: 2023 Jun 21.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Sarcoma, Ewing*/diagnostic imaging
Sarcoma, Ewing*/therapy
Sarcoma*/diagnosis
Sarcoma*/therapy
Sarcoma*/pathology
Retroperitoneal Neoplasms*/diagnosis
Retroperitoneal Neoplasms*/therapy
Retroperitoneal Neoplasms*/pathology
Soft Tissue Neoplasms*
Kidney Neoplasms*
Adult ; Humans

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 26.

Tytuł:

Dissociation protocols used for sarcoma tissues bias the transcriptome observed in single-cell and single-nucleus RNA sequencing.

Autorzy:

Truong DD; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Lamhamedi-Cherradi SE; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Porter RW; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Krishnan S; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Swaminathan J; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Gibson A; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Lazar AJ; Division of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Livingston JA; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Gopalakrishnan V; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Gordon N; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Daw NC; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Navin NE; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Gorlick R; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Ludwig JA; Sarcoma Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. .

Pokaż więcej

Źródło:

BMC cancer [BMC Cancer] 2023 May 31; Vol. 23 (1), pp. 488. Date of Electronic Publication: 2023 May 31.

Typ publikacji:

Journal Article

MeSH Terms:

Sarcoma*/genetics
Sarcoma, Ewing*/genetics
Sarcoma, Ewing*/pathology
Soft Tissue Neoplasms*
Humans ; Transcriptome ; Sequence Analysis, RNA/methods ; RNA-Seq/methods

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 27.

Tytuł:

Investigation of Flavonoid Scaffolds as DAX1 Inhibitors against Ewing Sarcoma through Pharmacoinformatic and Dynamic Simulation Studies.

Autorzy:

Yasir M; Department of Pharmacology, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.
Park J; Department of Pharmacology, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.
Han ET; Department of Medical Environmental Biology and Tropical Medicine, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.
Park WS; Department of Physiology, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.
Han JH; Department of Medical Environmental Biology and Tropical Medicine, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.
Kwon YS; College of Pharmacy, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.
Lee HJ; Department of Pharmacology, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.
Hassan M; The Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children's Hospital, Columbus, OH 43205, USA.
Kloczkowski A; The Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children's Hospital, Columbus, OH 43205, USA.
Chun W; Department of Pharmacology, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 May 26; Vol. 24 (11). Date of Electronic Publication: 2023 May 26.

Typ publikacji:

Journal Article

MeSH Terms:

Sarcoma, Ewing*/drug therapy
Sarcoma, Ewing*/genetics
Humans ; Receptors, Retinoic Acid/metabolism ; Repressor Proteins/genetics ; Molecular Docking Simulation

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 28.

Tytuł:

Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma.

Autorzy:

Shulman DS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
Merriam P; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
Choy E; Massachusetts General Hospital, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.
Guenther LM; St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Cavanaugh KL; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
Kao PC; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
Posner A; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
Bhushan K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
Fairchild G; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
Barker E; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.
Klega K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
Stegmaier K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
Crompton BD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
London WB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.

Pokaż więcej

Źródło:

Cancer medicine [Cancer Med] 2023 Jul; Vol. 12 (14), pp. 15207-15216. Date of Electronic Publication: 2023 Jun 12.

Typ publikacji:

Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Sarcoma, Ewing*/drug therapy
Humans ; Child ; Adolescent ; Young Adult ; Adult ; Neoplasm Recurrence, Local/drug therapy ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

SCR Disease Name:

Askin Tumor

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 29.

Tytuł:

Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies.

Autorzy:

Sánchez ML; Laboratory of Neuroanatomy of the Peptidergic Systems, Institute of Neurosciences of Castilla and León (INCYL), University of Salamanca, 37008 Salamanca, Spain.
Rodríguez FD; Department of Biochemistry and Molecular Biology, Faculty of Chemical Sciences, University of Salamanca, 37008 Salamanca, Spain.; Group GIR-USAL: BMD (Bases Moleculares del Desarrollo), University of Salamanca, 37008 Salamanca, Spain.
Coveñas R; Laboratory of Neuroanatomy of the Peptidergic Systems, Institute of Neurosciences of Castilla and León (INCYL), University of Salamanca, 37008 Salamanca, Spain.; Group GIR-USAL: BMD (Bases Moleculares del Desarrollo), University of Salamanca, 37008 Salamanca, Spain.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 Jun 09; Vol. 24 (12). Date of Electronic Publication: 2023 Jun 09.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Sarcoma, Ewing*
Breast Neoplasms*
Neuroblastoma*
Pancreatic Neoplasms*
Prostatic Neoplasms*
Liver Neoplasms*
Colorectal Neoplasms*
Male ; Humans ; Neuropeptide Y/metabolism ; Receptors, Neuropeptide Y/metabolism ; Neoplasm Recurrence, Local ; Peptide YY ; Pancreatic Neoplasms

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 30.

Tytuł:

Enhancing the Impact of Chemotherapy on Ewing Sarcoma Cells through Combination with Cold Physical Plasma.

Autorzy:

Nitsch A; Center for Orthopedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch-Straße, 17475 Greifswald, Germany.
Qarqash S; Center for Orthopedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch-Straße, 17475 Greifswald, Germany.
Römer S; Department of General Pharmacology, Institute of Pharmacology, Center of Drug Absorption and Transport (C_DAT), University Medicine Greifswald, 17487 Greifswald, Germany.
Schoon J; Center for Orthopedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch-Straße, 17475 Greifswald, Germany.
Ekkernkamp A; Center for Orthopedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch-Straße, 17475 Greifswald, Germany.; Department of Trauma and Orthopaedic Surgery, BG Klinikum Unfallkrankenhaus Berlin, Warener Straße 7, 12683 Berlin, Germany.
Niethard M; Center for Orthopedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch-Straße, 17475 Greifswald, Germany.; Sarcoma Centre, HELIOS-Klinikum Berlin-Buch, Schwanebecker Chaussee 50, 13125 Berlin, Germany.
Reichert JC; Center for Orthopedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch-Straße, 17475 Greifswald, Germany.
Wassilew GI; Center for Orthopedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch-Straße, 17475 Greifswald, Germany.
Tzvetkov MV; Department of General Pharmacology, Institute of Pharmacology, Center of Drug Absorption and Transport (C_DAT), University Medicine Greifswald, 17487 Greifswald, Germany.
Haralambiev L; Center for Orthopedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch-Straße, 17475 Greifswald, Germany.; Department of Trauma and Orthopaedic Surgery, BG Klinikum Unfallkrankenhaus Berlin, Warener Straße 7, 12683 Berlin, Germany.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 May 12; Vol. 24 (10). Date of Electronic Publication: 2023 May 12.

Typ publikacji:

Journal Article

MeSH Terms:

Sarcoma, Ewing*/pathology
Cytostatic Agents*/therapeutic use
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Bone Neoplasms*/metabolism
Child ; Humans ; Vincristine/pharmacology ; Vincristine/therapeutic use ; Doxorubicin/therapeutic use ; Cell Line, Tumor

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 31.

Tytuł:

Prospects and Advances in Adoptive Natural Killer Cell Therapy for Unmet Therapeutic Needs in Pediatric Bone Sarcomas.

Autorzy:

Bareke H; Translational Research Group in Pediatric Oncology, Haematopoietic Transplantation and Cell Therapy, Hospital La Paz Institute for Health Research, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.
Ibáñez-Navarro A; Translational Research Group in Pediatric Oncology, Haematopoietic Transplantation and Cell Therapy, Hospital La Paz Institute for Health Research, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.
Guerra-García P; Department of Pediatric Hemato-Oncology, La Paz University Hospital, 28046 Madrid, Spain.
González Pérez C; Department of Pediatric Hemato-Oncology, La Paz University Hospital, 28046 Madrid, Spain.
Rubio-Aparicio P; Department of Pediatric Hemato-Oncology, La Paz University Hospital, 28046 Madrid, Spain.
Plaza López de Sabando D; Department of Pediatric Hemato-Oncology, La Paz University Hospital, 28046 Madrid, Spain.
Sastre-Urgelles A; Department of Pediatric Hemato-Oncology, La Paz University Hospital, 28046 Madrid, Spain.
Ortiz-Cruz EJ; Department of Orthopedic Surgery and Traumatology, La Paz University Hospital, 28046 Madrid, Spain.
Pérez-Martínez A; Translational Research Group in Pediatric Oncology, Haematopoietic Transplantation and Cell Therapy, Hospital La Paz Institute for Health Research, IdiPAZ, La Paz University Hospital, 28046 Madrid, Spain.; Department of Pediatric Hemato-Oncology, La Paz University Hospital, 28046 Madrid, Spain.; School of Medicine, Autonomous University of Madrid, 28046 Madrid, Spain.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 May 05; Vol. 24 (9). Date of Electronic Publication: 2023 May 05.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Sarcoma, Ewing*/therapy
Osteosarcoma*/therapy
Neoplasms*/therapy
Sarcoma*
Bone Neoplasms*/therapy
Adolescent ; Humans ; Child ; Immunotherapy, Adoptive ; Killer Cells, Natural ; Immunotherapy ; Cell- and Tissue-Based Therapy

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 32.

Tytuł:

Validation of PRKCB Immunohistochemistry as a Biomarker for the Diagnosis of Ewing Sarcoma.

Autorzy:

Zota V; Department of Pathology, H. Lee Moffitt Cancer Center and Research Center, Tampa, FL, USA.
Siegal GP; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.
Kelly D; Department of Pathology and Laboratory, Children's of Alabama, University of Alabama at Birmingham, Birmingham, AL, USA.
Bridge JA; Molecular Pathology, ProPath, Dallas, TX, USA.; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.
Berglund A; Biostatistics and Bioinformatics Core, H. Lee Moffitt Cancer Center and Research Center, Tampa, FL, USA.
Bui K; Department of Pathology, H. Lee Moffitt Cancer Center and Research Center, Tampa, FL, USA.
Khalil F; Department of Pathology, H. Lee Moffitt Cancer Center and Research Center, Tampa, FL, USA.
R Reed D; Department of Individualized Cancer Management, H. Lee Moffitt Cancer Center and Research Center, Tampa, FL, USA.
Altiok S; Department of Pathology, H. Lee Moffitt Cancer Center and Research Center, Tampa, FL, USA.
Magliocco A; Department of Pathology, H. Lee Moffitt Cancer Center and Research Center, Tampa, FL, USA.
Bui MM; Department of Pathology, H. Lee Moffitt Cancer Center and Research Center, Tampa, FL, USA.

Pokaż więcej

Źródło:

Fetal and pediatric pathology [Fetal Pediatr Pathol] 2023 Apr; Vol. 42 (2), pp. 241-252. Date of Electronic Publication: 2022 Sep 05.

Typ publikacji:

Journal Article

MeSH Terms:

Sarcoma, Ewing*/diagnosis
Sarcoma, Ewing*/genetics
Sarcoma*
Humans ; Immunohistochemistry ; In Situ Hybridization, Fluorescence ; RNA-Binding Protein EWS/genetics ; Biomarkers ; Oncogene Proteins, Fusion/genetics ; Protein Kinase C beta/genetics ; Protein Kinase C beta/metabolism

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 33.

Tytuł:

Screening for DAX1/EWS-FLI1 functional inhibitors identified dihydroorotate dehydrogenase as a therapeutic target for Ewing's sarcoma.

Autorzy:

Watanabe M; Research and Development Division, Kyowa Kirin Co., Ltd., Shizuoka, Japan.; Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Kosaka H; Research and Development Division, Kyowa Kirin Co., Ltd., Shizuoka, Japan.
Sugawara M; Research and Development Division, Kyowa Kirin Co., Ltd., Shizuoka, Japan.
Maemoto M; Research and Development Division, Kyowa Kirin Co., Ltd., Shizuoka, Japan.
Ono Y; Research and Development Division, Kyowa Kirin Co., Ltd., Shizuoka, Japan.
Uemori T; Research and Development Division, Kyowa Kirin Co., Ltd., Shizuoka, Japan.
Shizu R; Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Yoshinari K; Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.

Pokaż więcej

Źródło:

Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (8), pp. 9802-9814. Date of Electronic Publication: 2023 Feb 24.

Typ publikacji:

Journal Article

MeSH Terms:

Sarcoma, Ewing*/drug therapy
Sarcoma, Ewing*/genetics
Sarcoma, Ewing*/metabolism
Humans ; Animals ; Mice ; Dihydroorotate Dehydrogenase ; Proto-Oncogene Protein c-fli-1/genetics ; RNA-Binding Protein EWS/genetics ; Oncogene Proteins, Fusion/genetics ; Oncogene Proteins, Fusion/metabolism ; Gene Expression Regulation, Neoplastic

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 34.

Tytuł:

Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma group.

Autorzy:

Brahmi M; Centre Léon Bérard, Lyon, France.
Gaspar N; Gustave Roussy Cancer Campus, Villejuif, France.
Gantzer J; ICANS, Strabourg, France.
Toulmonde M; Institut Bergonié, Bordeaux, France.
Boudou-Rouquette P; Hopital Cochin Saint Vincent de Paul, Paris, France.
Bompas E; ICO, Angers, France.
Firmin N; ICM, Montpellier, France.
Valentin T; Institut Claudius Regaud, Toulouse, France.
Cancel M; CHU Bretonneau, Tours, France.
Duffaud F; CHU Timone, Marseille, France.
Bertucci F; Institut Paoli-Calmettes, Marseille, France.
Perrin C; Centre Eugène Marquis, Rennes, France.
Dufresne A; Centre Léon Bérard, Lyon, France.
Marec-Bérard P; Centre Léon Bérard, Lyon, France.
Jean-Denis M; Centre Léon Bérard, Lyon, France.
Ray-Coquard I; Centre Léon Bérard, Lyon, France.
Le Loarer F; Institut Bergonié, Bordeaux, France.
Pierron G; Institut Curie, Paris, France.
Tirode F; Centre Léon Bérard, Lyon, France.
Blay JY; Centre Léon Bérard, Lyon, France.
Watson S; Institut Curie, Paris, France.

Pokaż więcej

Źródło:

Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (7), pp. 7801-7807. Date of Electronic Publication: 2022 Dec 20.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Sarcoma, Ewing*/genetics
Sarcoma, Ewing*/therapy
Sarcoma, Ewing*/diagnosis
Sarcoma, Small Cell*/diagnosis
Sarcoma, Small Cell*/pathology
Sarcoma*/epidemiology
Sarcoma*/genetics
Sarcoma*/therapy
Bone Neoplasms*/epidemiology
Bone Neoplasms*/genetics
Bone Neoplasms*/therapy
Soft Tissue Neoplasms*/genetics
Soft Tissue Neoplasms*/therapy
Soft Tissue Neoplasms*/diagnosis
Skin Neoplasms*
Adult ; Humans ; Male ; Female ; Child ; Child, Preschool ; Adolescent ; Young Adult ; Middle Aged ; Aged ; Aged, 80 and over ; Retrospective Studies ; Death ; Oncogene Proteins, Fusion ; Biomarkers, Tumor

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 35.

Tytuł:

Extracorporeal irradiation in malignant bone tumors: Single institution experience and review of literature.

Autorzy:

Agarwal S; Department of Radiation Oncology, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, India.
Rathi AK; Department of Radiation Oncology, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, India.
Singh K; Department of Radiation Oncology, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, India.
Melgandi W; Department of Radiation Oncology, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, India.
Ansari FA; Department of Radiation Oncology, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, India.
Arora S; Department of Radiation Oncology, Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi, India.

Pokaż więcej

Źródło:

Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Apr; Vol. 19 (Supplement), pp. S1-S5.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Bone Neoplasms*/radiotherapy
Bone Neoplasms*/surgery
Sarcoma, Ewing*/radiotherapy
Sarcoma, Ewing*/surgery
Osteosarcoma*/radiotherapy
Osteosarcoma*/surgery
Male ; Female ; Humans ; Young Adult ; Adult ; Treatment Outcome ; Bone and Bones

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 36.

Tytuł:

Primary adrenal Ewing's sarcoma family of tumors with tumor thrombus of the inferior vena cava: a case report.

Autorzy:

Atagi K; Department of Urology, Kochi Medical School, Nankoku, 783-8505, Japan.
Karashima T; Department of Urology, Kochi Medical School, Nankoku, 783-8505, Japan. .; Department of Urology, Kochi Medical School, Kochi University, Kohasu, Oko, Nankoku, Kochi, 783-8505, Japan. .
Mizutani K; Department of Urology, Kochi Medical School, Nankoku, 783-8505, Japan.
Fukuhara H; Department of Urology, Kochi Medical School, Nankoku, 783-8505, Japan.
Fukata S; Department of Urology, Kochi Medical School, Nankoku, 783-8505, Japan.
Miura Y; Department of Cardiovascular Surgery, Kochi Medical School, Nankoku, 783-8505, Japan.
Mitsuishi A; Department of Cardiovascular Surgery, Kochi Medical School, Nankoku, 783-8505, Japan.
Hanazaki K; Department of Digestive Surgery, Kochi Medical School, Nankoku, 783-8505, Japan.
Uemura S; Department of Digestive Surgery, Kochi Medical School, Nankoku, 783-8505, Japan.
Miyazaki R; Department of Respirator Surgery, Kochi Medical School, Nankoku, 783-8505, Japan.
Anayama T; Department of Respirator Surgery, Kochi Medical School, Nankoku, 783-8505, Japan.
Yamane M; Department of Respiratory Medicine, Kochi Medical School, Nankoku, 783-8505, Japan.
Sakai M; Department of Respiratory Medicine, Kochi Medical School, Nankoku, 783-8505, Japan.
Iguchi M; Laboratory of Diagnostic Pathology, Kochi Medical School Hospital, Nankoku, 783-8505, Japan.
Yorita K; Department of Diagnostic Pathology, Japanese Red Cross Kochi Hospital, Kochi, 780-8562, Japan.
Inoue K; Department of Urology, Kochi Medical School, Nankoku, 783-8505, Japan.

Pokaż więcej

Źródło:

Journal of medical case reports [J Med Case Rep] 2023 Mar 24; Vol. 17 (1), pp. 108. Date of Electronic Publication: 2023 Mar 24.

Typ publikacji:

Case Reports; Journal Article

MeSH Terms:

Sarcoma, Ewing*/diagnostic imaging
Sarcoma, Ewing*/surgery
Thrombosis*/drug therapy
Female ; Humans ; Young Adult ; Adult ; Vena Cava, Inferior/diagnostic imaging ; Vena Cava, Inferior/surgery ; Chemotherapy, Adjuvant ; Abdomen

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 37.

Tytuł:

Rare Case of BCOR::CCNB3 Sarcoma of Bone.

Autorzy:

Arai Y; Department of Orthopaedic Oncology and Surgery, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Yazawa Y; Department of Orthopaedic Oncology and Surgery, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.; Department of Orthopaedic Surgery, Symphony Clinic, Utsunomiya, Tochigi, Japan.
Torigoe T; Department of Orthopaedic Oncology and Surgery, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Imanishi J; Department of Orthopaedic Oncology and Surgery, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.; Department of Orthopaedic Surgery, Teikyo University Graduate School of Medicine, Tokyo, Japan.
Motoi T; Department of Pathology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Yasuda M; Department of Diagnostic Pathology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Tanaka R; Department of Pediatric Hematology and Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Fukushima T; Department of Pediatric Hematology and Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Watanabe A; Department of Pediatric Hematology and Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Ohta A; Department of Pediatric Hematology and Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Shimizu Y; Department of Pediatric Hematology and Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Kadono Y; Department of Orthopaedic Surgery, Saitama Medical University Hospital, Moroyama, Saitama, Japan.
Saita K; Department of Orthopaedic Surgery, Saitama Medical University, Saitama Medical Center, Kawagoe, Saitama, Japan.

Pokaż więcej

Źródło:

The American journal of case reports [Am J Case Rep] 2023 Mar 14; Vol. 24, pp. e938158. Date of Electronic Publication: 2023 Mar 14.

Typ publikacji:

Case Reports; Journal Article

MeSH Terms:

Sarcoma, Ewing*/diagnosis
Sarcoma, Ewing*/pathology
Sarcoma*/pathology
Soft Tissue Neoplasms*/pathology
Male ; Humans ; Adolescent ; Proto-Oncogene Proteins/genetics ; Repressor Proteins/genetics ; Biomarkers, Tumor ; Cyclin B

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 38.

Tytuł:

Hypoxia and HIFs in Ewing sarcoma: new perspectives on a multi-facetted relationship.

Autorzy:

Ceranski AK; Hopp-Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Translational Pediatric Sarcoma Research (B410), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Carreño-Gonzalez MJ; Hopp-Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Translational Pediatric Sarcoma Research (B410), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Ehlers AC; Hopp-Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Translational Pediatric Sarcoma Research (B410), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Colombo MV; Hopp-Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Translational Pediatric Sarcoma Research (B410), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Regenerative Medicine Technologies Laboratory, Laboratories for Translational Research (LRT), Ente Ospedaliero Cantonale (EOC), Via F. Chiesa 5, CH-6500, Bellinzona, Switzerland.; Department of Surgery, Service of Orthopaedics and Traumatology, EOC, Lugano, Switzerland.; Department of Chemistry, Materials and Chemical Engineering 'Giulio Natta', Politecnico Di Milano, Via Mancinelli 7, 20131, Milan, Italy.
Cidre-Aranaz F; Hopp-Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Translational Pediatric Sarcoma Research (B410), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Grünewald TGP; Hopp-Children's Cancer Center (KiTZ), Heidelberg, Germany. .; Division of Translational Pediatric Sarcoma Research (B410), German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. .; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. .

Pokaż więcej

Źródło:

Molecular cancer [Mol Cancer] 2023 Mar 13; Vol. 22 (1), pp. 49. Date of Electronic Publication: 2023 Mar 13.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Sarcoma, Ewing*/genetics
Sarcoma, Ewing*/pathology
Humans ; Child ; Oncogene Proteins, Fusion/genetics ; Proteins/metabolism ; RNA-Binding Protein EWS/genetics ; RNA-Binding Protein EWS/metabolism ; Hypoxia/genetics ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic ; Tumor Microenvironment

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 39.

Tytuł:

Targeting B7-H3-A Novel Strategy for the Design of Anticancer Agents for Extracranial Pediatric Solid Tumors Treatment.

Autorzy:

Rasic P; Department of Abdominal Surgery, Mother and Child Health Care Institute of Serbia 'Dr. Vukan Cupic', 11000 Belgrade, Serbia.
Jeremic M; Institute of Medical and Clinical Biochemistry, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Jeremic R; Institute of Medical Physiology 'Richard Burian', Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Dusanovic Pjevic M; Institute of Human Genetics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Rasic M; Institute of Human Genetics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Djuricic SM; Department of Clinical Pathology, Mother and Child Health Care Institute of Serbia 'Dr. Vukan Cupic', 11000 Belgrade, Serbia.; Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina.
Milickovic M; Department of Abdominal Surgery, Mother and Child Health Care Institute of Serbia 'Dr. Vukan Cupic', 11000 Belgrade, Serbia.; Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Vukadin M; Department of Abdominal Surgery, Mother and Child Health Care Institute of Serbia 'Dr. Vukan Cupic', 11000 Belgrade, Serbia.
Mijovic T; Department of Abdominal Surgery, Mother and Child Health Care Institute of Serbia 'Dr. Vukan Cupic', 11000 Belgrade, Serbia.
Savic D; Department of Abdominal Surgery, Mother and Child Health Care Institute of Serbia 'Dr. Vukan Cupic', 11000 Belgrade, Serbia.; Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.

Pokaż więcej

Źródło:

Molecules (Basel, Switzerland) [Molecules] 2023 Apr 11; Vol. 28 (8). Date of Electronic Publication: 2023 Apr 11.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Sarcoma, Ewing*
Neuroblastoma*/drug therapy
Immunoconjugates*
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Humans ; Child ; B7 Antigens ; Immunotherapy

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 40.

Tytuł:

The potential of PARP as a therapeutic target across pediatric solid malignancies.

Autorzy:

Keller KM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Koetsier J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Schild L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Amo-Addae V; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Eising S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
van den Handel K; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Ober K; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Koopmans B; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Essing A; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
van den Boogaard ML; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Langenberg KPS; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Jäger N; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
Kool M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
Pfister S; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
Dolman MEM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Children's Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Kensington, NSW, Australia.; School of Women's and Children's Health, Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia.
Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. .; Department of Pharmaceutical Sciences, University Utrecht, Utrecht, the Netherlands. .
van Hooff SR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

Pokaż więcej

Źródło:

BMC cancer [BMC Cancer] 2023 Apr 05; Vol. 23 (1), pp. 310. Date of Electronic Publication: 2023 Apr 05.

Typ publikacji:

Journal Article

MeSH Terms:

Antineoplastic Agents*/therapeutic use
Sarcoma, Ewing*/drug therapy
Neuroblastoma*/pathology
Cerebellar Neoplasms*/drug therapy
Humans ; Child ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use ; Cell Line, Tumor

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 41.

Tytuł:

Long-term follow-up results of pediatric and adolescent patients with localized Ewing sarcoma treated based on stratified modalities.

Autorzy:

Zeng C; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.; Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Chen T; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.; Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Wang J; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.; Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Sun F; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.; Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Huang J; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.; Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Lu S; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.; Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Zhu J; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.; Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Zhang Y; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.; Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Sun X; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.; Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Zhen Z; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.; Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.

Pokaż więcej

Źródło:

Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (8), pp. 9409-9419. Date of Electronic Publication: 2023 Feb 21.

Typ publikacji:

Journal Article

MeSH Terms:

Sarcoma, Ewing*/pathology
Bone Neoplasms*/pathology
Child ; Humans ; Adolescent ; Follow-Up Studies ; Retrospective Studies ; Treatment Outcome ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Combined Modality Therapy

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 42.

Tytuł:

Bibliometric analysis of Ewing sarcoma from 1993 to 2022.

Autorzy:

Han G; Department of Orthopaedics Surgery, West China Hospital, Sichuan University, Chengdu, China.
Liu T; Department of Orthopaedics Surgery, West China Hospital, Sichuan University, Chengdu, China.
Kang P; Department of Orthopaedics Surgery, West China Hospital, Sichuan University, Chengdu, China. .

Pokaż więcej

Źródło:

BMC cancer [BMC Cancer] 2023 Mar 24; Vol. 23 (1), pp. 272. Date of Electronic Publication: 2023 Mar 24.

Typ publikacji:

Journal Article

MeSH Terms:

Sarcoma, Ewing*/genetics
Sarcoma*
Neuroectodermal Tumors, Primitive*
Soft Tissue Neoplasms*
Humans ; Bibliometrics ; Genomics ; Translocation, Genetic

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 43.

Tytuł:

The clinical characteristics, novel predictive tool, and risk classification system for primary Ewing sarcoma patients that underwent chemotherapy: A large population-based retrospective cohort study.

Autorzy:

Huang C; Department of Orthopedics, West China Hospital of Sichuan University, Chengdu, China.
Yu QP; Health Management Center, West China Hospital of Sichuan University, Chengdu, China.
Ding Z; Department of Orthopedics, West China Hospital of Sichuan University, Chengdu, China.
Zhou Z; Department of Orthopedics, West China Hospital of Sichuan University, Chengdu, China.
Shi X; Department of Orthopedics, West China Hospital of Sichuan University, Chengdu, China.

Pokaż więcej

Źródło:

Cancer medicine [Cancer Med] 2023 Mar; Vol. 12 (5), pp. 6244-6259. Date of Electronic Publication: 2022 Oct 21.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Sarcoma, Ewing*/drug therapy
Humans ; Retrospective Studies ; Nomograms ; Area Under Curve ; Calibration ; SEER Program ; Prognosis

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 44.

Tytuł:

Immature platelet fraction predicts early marrow recovery after severe chemotherapy associated neutropenia.

Autorzy:

Salvador C; Division of Hematology and Oncology, Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Meryk A; Division of Hematology and Oncology, Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Hetzer B; Division of Hematology and Oncology, Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Bargehr C; Division of Hematology and Oncology, Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Kropshofer G; Division of Hematology and Oncology, Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Meister B; Division of Hematology and Oncology, Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Anliker M; Central Institute for Medical and Chemical Laboratory Diagnosis, Medical University of Innsbruck, Innsbruck, Austria.
Crazzolara R; Division of Hematology and Oncology, Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria. .

Pokaż więcej

Źródło:

Scientific reports [Sci Rep] 2023 Feb 27; Vol. 13 (1), pp. 3371. Date of Electronic Publication: 2023 Feb 27.

Typ publikacji:

Journal Article

MeSH Terms:

Neuroectodermal Tumors, Primitive, Peripheral*
Sarcoma, Ewing*/drug therapy
Febrile Neutropenia*
Child ; Humans ; Bone Marrow ; Retrospective Studies ; Blood Platelets ; C-Reactive Protein ; Vegetables

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 45.

Tytuł:

A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation.

Autorzy:

Metts JL; Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St Petersburg, Florida, USA.
Trucco M; Cleveland Clinic Children's Hospital, Department of Pediatric Hematology-Oncology & Bone Marrow Transplantation, Cleveland, Ohio, USA.
Weiser DA; Departments of Pediatrics and Genetics, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
Thompson P; Division of Pediatric Hematology-Oncology, University of North Carolina Health Care, Chapel Hill, North Carolina, USA.
Sandler E; Department of Pediatric Oncology, Nemours Health Systems, Jacksonville, Florida, USA.
Smith T; Cognitive Research Corporation, St Petersburg, Florida, USA.
Crimella J; Clinical Trials Office Partnerships, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Sansil S; Cancer Pharmacokinetics and Pharmacodynamic Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Thapa R; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Fridley BL; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Llosa N; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Badgett T; Department of Pediatrics, University of Kentucky College of Medicine, Lexington, Kentucky, USA.
Gorlick R; Department of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Reed D; Adolescent and Young Adult Program, Department of Interdisciplinary Cancer Management, H. Lee Moffitt Cancer Center, Tampa, Florida, USA.
Gill J; Department of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Pokaż więcej

Źródło:

Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (4), pp. 4270-4281. Date of Electronic Publication: 2022 Sep 23.

Typ publikacji:

Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

MeSH Terms:

Sarcoma, Ewing*/drug therapy
Metformin*/therapeutic use
Neoplasms*/drug therapy
Neoplasms*/etiology
Central Nervous System Neoplasms*/drug therapy
Child ; Humans ; Child, Preschool ; Adolescent ; Irinotecan/adverse effects ; Temozolomide/therapeutic use ; Vincristine/therapeutic use ; Camptothecin ; Dacarbazine ; Maximum Tolerated Dose ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics ; Neoplasm Recurrence, Local/drug therapy

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 46.

Tytuł:

Ewing Sarcoma Displaying Extensive Well Differentiated Neuroblastomatous Differentiation: A Case Report.

Autorzy:

Çomunoğlu N; Department of Pathology, Istanbul University-Cerrahpaşa Carrahpaşa Faculty of Medicine, Istanbul, Turkey.
Çomunoğlu C; Department of Pathology, Prof. Dr. C. Taşçıoğlu Ş. Hospital, Istanbul, Turkey.
Özcan R; Department of Pediatric Surgery, Istanbul University-Cerrahpaşa Carrahpaşa Faculty of Medicine, Istanbul, Turkey.
Ocak S; Department of Pediatric Hematology and Oncology, Istanbul University-Cerrahpaşa Carrahpaşa Faculty of Medicine, Istanbul, Turkey.

Pokaż więcej

Źródło:

Fetal and pediatric pathology [Fetal Pediatr Pathol] 2023 Feb; Vol. 42 (1), pp. 156-160. Date of Electronic Publication: 2022 May 10.

Typ publikacji:

Case Reports; Journal Article

MeSH Terms:

Sarcoma, Ewing*/diagnosis
Sarcoma*
Female ; Humans ; Child ; RNA-Binding Protein EWS/genetics ; Cell Differentiation ; Biopsy ; Biomarkers, Tumor/analysis

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 47.

Tytuł:

Exploration of Flavonoids as Lead Compounds against Ewing Sarcoma through Molecular Docking, Pharmacogenomics Analysis, and Molecular Dynamics Simulations.

Autorzy:

Yasir M; Department of Pharmacology, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.
Park J; Department of Pharmacology, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.
Han ET; Department of Medical Environmental Biology and Tropical Medicine, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.
Park WS; Department of Physiology, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.
Han JH; Department of Medical Environmental Biology and Tropical Medicine, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.
Kwon YS; College of Pharmacy, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.
Lee HJ; Department of Pharmacology, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.
Hassan M; The Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children's Hospital, Columbus, OH 43205, USA.
Kloczkowski A; The Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children's Hospital, Columbus, OH 43205, USA.
Chun W; Department of Pharmacology, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.

Pokaż więcej

Źródło:

Molecules (Basel, Switzerland) [Molecules] 2023 Jan 03; Vol. 28 (1). Date of Electronic Publication: 2023 Jan 03.

Typ publikacji:

Journal Article

MeSH Terms:

Sarcoma, Ewing*/drug therapy
Sarcoma, Ewing*/genetics
Bone Neoplasms*/pathology
Child ; Humans ; Molecular Docking Simulation ; RNA-Binding Protein EWS/genetics ; RNA-Binding Protein EWS/metabolism ; Molecular Dynamics Simulation ; Flavonoids/pharmacology ; Pharmacogenetics ; Proto-Oncogene Protein c-fli-1/genetics ; Proto-Oncogene Protein c-fli-1/metabolism ; Gene Expression Regulation, Neoplastic ; Cell Line, Tumor

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 48.

Tytuł:

Ewing's sarcoma masquerading as an odontogenic infection.

Autorzy:

Hamid R; Department of Oral Medicine and Radiology, Maulana Azad Institute of Dental Sciences, B.S.Z. Marg, New Delhi, India.
Gaur A
Gupta S
Garg R

Pokaż więcej

Źródło:

Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Jan 01; Vol. 19 (Suppl 2), pp. S950-S953. Date of Electronic Publication: 2023 Apr 28.

Typ publikacji:

Case Reports; Journal Article

MeSH Terms:

Sarcoma, Ewing*/diagnosis
Sarcoma, Ewing*/pathology
Bone Neoplasms*/diagnosis
Bone Neoplasms*/pathology
Osteosarcoma*/diagnosis
Sarcoma*
Child ; Female ; Humans ; Adolescent

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 49.

Tytuł:

Unusual case presentation associated with impacted mandibular molars: Clinicopathological correlation and immunohistochemical analysis.

Autorzy:

Patil K; Department of Oral Medicine and Radiology, JSS Dental College and Hospital, A Constituent College of JSS Academy of Higher Education and Research, Mysore, Karnataka, India.
Doddawad VG; Department of Oral Pathology and Microbiology, JSS Dental College and Hospital, A Constituent College of JSS Academy of Higher Education and Research, Mysore, Karnataka, India.
Sanjay CJ; Department of Oral Medicine and Radiology, JSS Dental College and Hospital, A Constituent College of JSS Academy of Higher Education and Research, Mysore, Karnataka, India.
Shivananda S; Department of Oral and Maxillofacial Surgery, JSS Dental College and Hospital, A Constituent College of JSS Academy of Higher Education and Research, Mysore, Karnataka, India.

Pokaż więcej

Źródło:

Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Jan 01; Vol. 19 (Suppl 2), pp. S986-S990. Date of Electronic Publication: 2023 Apr 30.

Typ publikacji:

Case Reports; Journal Article

MeSH Terms:

Jaw Neoplasms*
Sarcoma, Ewing*/diagnosis
Sarcoma, Ewing*/pathology
Adolescent ; Humans ; Male ; Immunohistochemistry ; Mandible/diagnostic imaging ; Mandible/pathology ; Prognosis

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 50.

Tytuł:

Ewing and Ewing-like sarcomas: A morphological guide through genetically-defined entities.

Autorzy:

Yoshida A; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.; Rare Cancer Center, National Cancer Center, Tokyo, Japan.

Pokaż więcej

Źródło:

Pathology international [Pathol Int] 2023 Jan; Vol. 73 (1), pp. 12-26. Date of Electronic Publication: 2022 Dec 09.

Typ publikacji:

Journal Article; Review

MeSH Terms:

Sarcoma, Ewing*/diagnosis
Sarcoma, Ewing*/genetics
Sarcoma, Ewing*/pathology
Sarcoma*/diagnosis
Sarcoma, Small Cell*/diagnosis
Sarcoma, Small Cell*/genetics
Sarcoma, Small Cell*/pathology
Bone Neoplasms*/diagnosis
Bone Neoplasms*/genetics
Humans ; Transcription Factors/genetics ; Biomarkers, Tumor/genetics ; Oncogene Proteins, Fusion/genetics

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły